{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:58:04Z","timestamp":1780617484181,"version":"3.54.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Recent studies have focused on treating cardiac sarcoidosis (CS) with corticosteroids primarily mitigating symptoms and reducing the risk of mortality and other cardiovascular complications. A promising new treatment approach involves tumor necrosis factor (TNF) alpha inhibitors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology:<\/jats:title>\n            <jats:p>A systematic search was conducted on PubMed, the Cochrane Library, and Elsevier\u2019s Science Direct databases to identify studies comparing TNF alpha inhibitors with other drugs in CS patients who had heart failure. The analyses were conducted using the random-effects model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study\u2019s primary outcome is an increase in ejection fraction (EF), secondary outcomes include a reduction in the dose of prednisone at 6 and 12 months, maximum standardized uptake value by cardiac tissue, and fluorodeoxyglucose uptake by cardiac myocytes on positron emission tomography scan. The total number of pooled participants was 154 out of which 140 met the Heart Rhythm Society criteria for CS. The pooled analysis showed that treatment with the TNF alpha inhibitors was associated with a significant increase in EF [weighted mean difference (WMD), 46.272; 95% confidence interval (CI), 40.60\u201351.94, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>, 75.74%], reduction in the dose of prednisone at 6 months (WMD, 9.20; 95% CI, 7.65\u201310.75; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>, 13.33%) and at 12 months (WMD, 6.40; 95% CI, 4.74\u20138.07; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>, 9.37%); decrease in myocardial maximum standardized uptake value (WMD, 1.99; 95% CI, 0.91\u20133.06; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>: 97%) and reduction in fluorodeoxyglucose uptake by cardiac myocytes (WMD, 1.55; 95% CI, 1.09\u20132.00; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>, 32.29) on positron emission tomography scans.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The research findings suggest that TNF alpha inhibitors improve EF, reduce required steroid dosage, and improve clinical outcomes. Nonetheless, further high-quality randomized controlled trials with large sample sizes are needed to assess other impacts of this therapy on patients with CS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000364","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T21:01:35Z","timestamp":1732309295000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["TNF alpha Inhibitors in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"23","author":[{"given":"Asma","family":"Mahmood","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor Farooq","family":"Raja","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba","family":"Imran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Zahoor","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadiq","family":"Khan Khakwani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Multan Medical and Dental College, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Duseja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihtisham","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lady Reading Hospital, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Murtaza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Quaid-e-Azam Medical College, Bahawalpur, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad Faizan","family":"Abid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sohail","family":"Sattar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Binzhou Medical College, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Bajaj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College, Lyari, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saneha","family":"Bajaj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Peoples University of Medical and Health Sciences (For Women), Nawabshah, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiqa","family":"Tariq","sequence":"additional","affiliation":[{"name":"Department of Medicine, Multan Medical and Dental College, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimen","family":"Shafiq","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjcard.2023.08.085","article-title":"Tumor necrosis factor-\u03b1 inhibitors in cardiac sarcoidosis management: evaluating therapeutic efficacy and future directions.","volume":"205","author":"Chaudhary","year":"2023","journal-title":"Am J Cardiol"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0040-1712535","article-title":"Cardiac sarcoidosis.","volume":"41","author":"Birnie","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience.","volume":"27","author":"Gilotra","year":"2021","journal-title":"J Card Fail"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5582\/irdr.2022.01123","article-title":"Treat to target and tight control: could be a new approach in the treatment of sarcoidosis?.","volume":"12","author":"Kobak","year":"2023","journal-title":"Intractable Rare Dis Res"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2023.07.139","article-title":"Clinical response to tumor necrosis factor-\u03b1 inhibitor therapy in the management of cardiac sarcoidosis.","volume":"205","author":"Churchill","year":"2023","journal-title":"Am J Cardiol"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis.","volume":"124","author":"Harper","year":"2019","journal-title":"Am J Cardiol"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2021.02.022","article-title":"Effectiveness and safety of infliximab in Cardiac Sarcoidosis.","volume":"330","author":"Bakker","year":"2021","journal-title":"Int J Cardiol"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"107004","DOI":"10.1016\/j.rmed.2022.107004","article-title":"Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: a retrospective analysis demonstrating a benefit of infliximab.","volume":"203","author":"Judson","year":"2022","journal-title":"Respir Med"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2217\/imt.14.65","article-title":"Anti-TNF therapeutics for the treatment of sarcoidosis.","volume":"6","author":"Crommelin","year":"2014","journal-title":"Immunotherapy"},{"key":"R13-20250506","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.","volume":"115","author":"Baughman","year":"1990","journal-title":"J Lab Clin Med"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1536\/ihj.21-164","article-title":"Cytokine signaling and matrix remodeling pathways associated with cardiac sarcoidosis disease activity defined using FDG PET imaging.","volume":"62","author":"Young","year":"2021","journal-title":"Int Heart J"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis.","volume":"50","author":"Baker","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R16-20250506","first-page":"100782","article-title":"Non-steroidal treatment of cardiac sarcoidosis: a systematic review.","volume":"34","author":"Gallegos","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"R17-20250506","first-page":"76","article-title":"Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.","volume":"25","author":"Baughman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/art.21468","article-title":"Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.","volume":"53","author":"Sweiss","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:01:41Z","timestamp":1746558101000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000364","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}